Latest News about MRK
Recent news which mentions MRK
From Benzinga
From Benzinga
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
May 27, 2024
From Benzinga
From Benzinga
From Motley Fool
From InvestorPlace
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma Treatment
May 13, 2024
From Benzinga
From Benzinga
From InvestorPlace
From InvestorPlace
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy
May 03, 2024
From Benzinga
From Benzinga
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
May 02, 2024
From Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
From Benzinga
From Benzinga
Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
April 25, 2024
From Benzinga
S&P 500 Down Over 1%; Merck Increases 2024 Outlook
April 25, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.